Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma

byiShook Opinion
Sep 27, 2024 - 18:00

Share

Legend Biotech said Friday its cancer drug, Carvykti, lowered the risk of death by 45% in a study of multiple myeloma patients. The post Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma appeared first on Investor's Business Daily.

Legend Biotech said Friday its cancer drug, Carvykti, lowered the risk of death by 45% in a study of multiple myeloma patients.

The post Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma appeared first on Investor's Business Daily.